Hiroyuki Shimada
8PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Aug 28, 2025
Intravitreal Povidone-Iodine Injection and Low-Dose Antibiotic Irrigation for Infectious Endophthalmitis: A Retrospective Case Series.Yumiko Machida, Hiroyuki Nakashizuka, Hajime Onoe
|Apr 23, 2022
One-Year Outcome of Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injections for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.Yorihisa Kitagawa, Hiroyuki Shimada, Ryusaburo Mori
|Feb 24, 2022
Bilateral Pachychoroid disease with type 3 Uveal effusion syndrome in one eye and central serous Chorioretinopathy in contralateral eye: a case report.Hajime Onoe, Hiroyuki Shimada, Akiyuki Kawamura
|Feb 15, 2022
Safety Measures for Maintaining Low Endophthalmitis Rate after Intravitreal Anti-Vascular Endothelial Growth Factor Injection before and during the COVID-19 Pandemic.Koji Tanaka, Hiroyuki Shimada, Ryusaburo Mori
|Sep 05, 2021
A case of bilateral pachychoroid disease: polypoidal choroidal vasculopathy in one eye and peripheral exudative hemorrhagic chorioretinopathy in contralateral eye.Yorihisa Kitagawa, Hiroyuki Shimada, Akiyuki Kawamura
|Oct 05, 2018
Surgical outcomes of 27-gauge and 25-gauge vitrectomy day surgery for proliferative diabetic retinopathy.Zeon Naruse, Hiroyuki Shimada, Ryusaburo Mori
Pageof 2
